Key Highlights
- ixEngage enables biopharma to connect with patients through compliant, cloud-based infrastructure.
- Virtual patient experience with clinical onboarding, lab result delivery, and ongoing care coordination.
- Multimodal lab testing offers flexibility with self-collection kits, mobile phlebotomy, and lab options.
- Prescription fulfillment through e-prescribing, home delivery, and secure patient notifications.
- Analytics provides partners with performance tracking and actionable insights.
Source: Business Wire
Notable Quote
- “We believe the future of biopharma success will hinge on more proactive, data-driven collaboration with patients.” — Pouria Sanae, CEO and Co-founder at ixlayer
SoHC's Take
ixlayer’s unveiling of ixEngage represents a significant step forward for biopharma in creating efficient, patient-centric healthcare solutions. By streamlining the connection between biopharma, labs, and patients, ixEngage promises to enhance care delivery while meeting stringent industry regulations. Its ability to integrate with disease state awareness campaigns and provide actionable lab data positions ixlayer as a key player in the evolution of healthcare marketing strategies.
